About CancerGene Connect
CancerGene Connect is a company based in Dallas (United States) founded in 2015 was acquired by Invitae in June 2017. CancerGene Connect has raised $300 thousand across 1 funding round from investors including Invitae. CancerGene Connect operates in a competitive market with competitors including Helix, Benchling, BioAge Labs, Ingenuity Systems and Genuity Science, among others.
- Headquarter Dallas, United States
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of CancerGene Connect
CancerGene Connect has successfully raised a total of $300K through 1 strategic funding round. The most recent funding activity was a Seed round of $300 thousand completed in October 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in CancerGene Connect
CancerGene Connect has secured backing from 1 investor. Prominent investors backing the company include Invitae.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Home-based genetic tests for detecting diseases are provided to individuals.
|
Locked | Locked | Locked |
Investor details for CancerGene Connect
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CancerGene Connect
Investment portfolio details for CancerGene Connect
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CancerGene Connect
Detailed financials for CancerGene Connect
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cancergene Connect Comparisons
Peer comparison for CancerGene Connect
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CancerGene Connect
CancerGene Connect operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Benchling, BioAge Labs, Ingenuity Systems and Genuity Science, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomic database for clinical research is provided.
|
|
| Locked | Locked | Locked |
Cloud-based bioinformatics platform is offered for biotech research.
|
|
| Locked | Locked | Locked |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
|
| Locked | Locked | Locked |
Genomic data is analyzed and interpreted via web-based applications.
|
|
| Locked | Locked | Locked |
AI-based omics data analysis solutions are provided to researchers.
|
|
| Locked | Locked | Locked |
Provider of bio informatics platform to develops biologics and therapeutics
|
Detailed competitors of CancerGene Connect
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cancergene Connect
Complete news archive for CancerGene Connect
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CancerGene Connect
CancerGene Connect was founded in 2015 and raised its 1st funding round 1 year after it was founded.
CancerGene Connect is headquartered in Dallas, United States. It is registered at Dallas, Texas, United States.
CancerGene Connect is a funded company, having raised a total of $300K across 1 funding round to date.
CancerGene Connect was founded in 2015 in Dallas, United States, as a cloud-based SaaS provider in the health technology sector. Genetic counseling productivity tools, developed by UT Southwestern, are utilized to identify patients with genetic predispositions to cancers. Patient history is gathered remotely, risk assessment models are executed, family trees are constructed, reports are generated for patients, and a comprehensive database is maintained.
CancerGene Connect's top competitors include Helix, Benchling and BioAge Labs.
CancerGene Connect has 1 investor. Key investors include Invitae.